${session.getAttribute("locale")} 5 Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness Wed 03 Aug 2016 15:08:10 AEST ]]> Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population Wed 03 Aug 2016 14:25:45 AEST ]]> Genetic Association of the KLK4 Locus with Risk of Prostate Cancer Wed 03 Aug 2016 14:25:26 AEST ]]> Association between prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in australia and a meta-analysis of GWAS data Wed 03 Aug 2016 14:11:33 AEST ]]> A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease Wed 03 Aug 2016 11:32:08 AEST ]]> A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population Tue 02 Aug 2016 09:32:24 AEST ]]> Risk analysis of prostate cancer in practical, a multinational consortium, using 25 known prostate cancer susceptibility loci Thu 05 Oct 2017 16:35:55 AEST ]]> The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness Mon 11 Sep 2017 12:12:12 AEST ]]> A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney Fri 29 Mar 2019 13:33:45 AEST ]]> Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Fri 25 May 2018 09:55:48 AEST ]]>